# OxSyBio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oxsybio

- Industry: Healthcare IT
- Headquarters: London, UK
- Website: www.oxsybio.com
- Total disclosed funding: $7M
- Latest round: Series A (Feb 14, 2018)
- Investors on record: 3

## About

OxSyBio Ltd. is a biotechnology company focused on developing synthetic biology solutions aimed at enabling advances in medical therapies and regenerative medicine through innovative techniques.Founded in 2014 and headquartered in London, UK, OxSyBio Ltd. specializes in synthetic biology. The company has undergone strategic developments, securing three funding deals, with its latest, a Series A round of GBP 5.000 mn, led by Woodford Patient Capital Trust on February 20, 2018. The total amount raised to date stands at GBP 5.000 mn, with a current company valuation of GBP 19.550 mn. Notably, the company was established by individuals with expertise in the biotech sector.OxSyBio Ltd. develops innovative synthetic biology solutions tailored for medical applications, particularly in regenerative medicine. The company focuses on creating advanced therapies that leverage synthetic biology techniques to improve healthcare outcomes.OxSyBio Ltd. generates revenue primarily through partnerships with research institutions and healthcare organizations seeking to leverage synthetic biology for therapeutic applications. Their business model centers around collaborative research and development agreements, which allow for revenue generation as they advance their product offerings.OxSyBio Ltd. is poised for growth with plans to launch new synthetic biology products within the next two years, targeting advancements in medical therapies. The company aims to expand into new markets in North America and Europe by 2025, utilizing funds from its recent GBP 5.000 mn Series A funding to support these initiatives and enhance its research capabilities.

## Funding rounds

- Series A, Feb 14, 2018, $7M — Longview Innovation, Parkwalk Advisors, Woodford Patient Capital Trust

## Investors

- Longview Innovation (https://capitalatlas.ai/funds/longview-innovation) — Series A
- Parkwalk Advisors (https://capitalatlas.ai/funds/parkwalk-advisors) — Series A
- Woodford Patient Capital Trust — Series A